On May 21-22, 2019 the FSEU Moscow Endocrine Plant took part in the XXI annual All-Russian Conference with international participation “State regulation in the field of pharmaceuticals and medical devices circulation - PharmMedObrashchenie-2019” (PMO-2019), organized by Roszdravnadzor.
In 2019 the event was attended by more than 1200 experts from 80 regions of the Russian Federation and 8 countries of the near and far abroad - representatives of federal and regional legislative and executive authorities of the Russian Federation, relevant foreign regulatory bodies and international organizations, research and public organizations, professional associations, wholesale and retail organizations and pharmaceutical manufacturers.
PharmMedObrashchenie is traditionally an authoritative platform for discussion of the development and regulation of the medical product market.
During the plenary session the Deputy Minister of Health of the Russian Federation Sergey Kraevoy read out a greeting from the Minister of Health of the Russian Federation Veronika Skvortsova to the conference participants and outlined the main tasks in the implementation of the National Healthcare project. The Head of Roszdravnadzor Mikhail Murashko in his report “2019 is a time of innovations” outlined the strategic objectives of the development of the healthcare system, as well as issues of purchases of drugs and medical products, labelling of drugs, including its legal support, aspects of control and supervision activities, harmonization of legislation in EEU framework.
The participants of the event also discussed changes in the field of registration and control of drug prices. In the framework of the topic “44-FL from 05.04.2013v: what is wrong with the purchases of drugs”, the possibility of creation of a new public purchase system and an algorithm of participation in large tenders of manufacturers, bypassing the chain of intermediaries, were considered.
Within the framework of the event the exhibition exposition of the FSUE Moscow Endocrine Plant was organized at which the presentation of the Accredited Testing Laboratory of the FSUE Moscow Endocrine Plant was held, working in accordance with the requirements of ISO-17025 and having a certified quality management system according to GOST R 52249-2009 (GMP).
Comment type is not specified in the component properties.